+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprotein Diagnostic Testing Market by Assay Type, Technology, End User, Application, Sample Type - Global Forecast to 2030- Product Image
Immunoprotein Diagnostic Testing Market by Assay Type, Technology, End User, Application, Sample Type - Global Forecast to 2030- Product Image
Sale

Immunoprotein Diagnostic Testing Market by Assay Type, Technology, End User, Application, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888817
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Immunoprotein diagnostic testing has become an essential tool for healthcare organizations seeking deeper clinical insights and improved disease management processes. As precision medicine gains traction, senior leaders and decision-makers are looking to optimized immunoprotein platforms to strengthen diagnostic confidence and support better therapeutic outcomes.

Market Snapshot: Immunoprotein Diagnostic Testing Market

The immunoprotein diagnostic testing market grew from USD 9.41 billion in 2024 to USD 10.07 billion in 2025. It is expected to continue growing at a CAGR of 6.94%, ultimately reaching USD 14.08 billion by 2030. This steady expansion is being shaped by evolving clinical requirements, advancements in assay technology, and regulatory influences across global healthcare systems. As diagnostic platforms become more sophisticated, market participants are looking to emerging opportunities driven by increased demand for swift, accurate, and cost-effective immunoprotein testing solutions.

Scope & Segmentation

  • Assay Types: Antibody tests (IgA, IgE, IgG, IgM, total antibody), antigen tests, and autoantibody tests provide broad detection coverage for various clinical needs.
  • Technologies: Platforms such as CLIA, ELISA, fluorescence polarization immunoassay, lateral flow immunoassay, and Western blot deliver flexibility in sensitivity, throughput, and integration within laboratory settings.
  • End Users: Diagnostic laboratories, clinics, hospitals, and research institutes represent the key stakeholders leveraging these platforms in both routine and specialized testing environments.
  • Applications: Utilized across autoimmune disorders (including multiple sclerosis and rheumatoid arthritis), cardiovascular diseases, infectious diseases (such as COVID-19 and hepatitis), and oncology indications.
  • Sample Types: Tests are designed for key specimen matrices including plasma, serum, urine, and whole blood to ensure broad applicability.
  • Regions: The report addresses market data and trends across the Americas, Europe/Middle East/Africa, and Asia-Pacific, including major markets such as the United States, Germany, China, and India.
  • Company Landscape: Analysis includes profiles and activities of Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Danaher, Ortho-Clinical Diagnostics, bioMérieux, DiaSorin, Bio-Rad Laboratories, and Fujirebio.

Key Takeaways for Senior Decision-Makers

  • Immunoprotein assay innovation is supporting earlier and more precise disease detection, which is valuable in both population screening and specialty medicine.
  • Automation and integration of cloud-based workflows help laboratories reduce errors, boost throughput, and enable seamless data sharing among clinical teams.
  • Platform flexibility now supports both centralized and decentralized deployment, extending critical diagnostic access to outpatient clinics and remote healthcare settings.
  • Strategic alliances between global instrument and reagent suppliers are enabling supply chain resilience and operational efficiencies, especially in response to regional regulatory shifts.
  • Segmentation by application highlights the growing relevance of personalized medicine approaches, particularly in autoimmune, infectious, and oncology testing.

Tariff Impact: Navigating the 2025 Regulatory Environment

New tariffs set to take effect in 2025 in the United States will raise procurement costs for imported assay reagents, kits, and diagnostic systems. These changes are prompting organizations to assess their supplier relationships and consider nearshoring or regional manufacturing to address potential cost pressures. Leaders adapting to these challenges are expected to explore cost-reducing innovation, optimize supply logistics, and strike new collaborative partnerships that help safeguard market share and ensure continued service delivery.

Methodology & Data Sources

This report is grounded in a multi-phase research process, combining comprehensive secondary research—such as published studies, regulatory documents, and industry papers—with in-depth interviews from clinical, executive, and technical thought leaders. Data validation was achieved using cross-referenced financial records, proprietary intelligence, and expert panel review, ensuring analytical integrity and relevance to market realities.

Why This Report Matters

  • Enables confident, evidence-based strategic planning for investment, operational alignment, and competitive positioning in immunoprotein diagnostics.
  • Equips senior leaders to anticipate the effects of changing tariff environments, regulatory trends, and regional shifts on technology adoption and procurement.
  • Supports targeted R&D prioritization, go-to-market tactics, and partnership development aligned with evolving market needs and customer demands.

Conclusion

With rapid advances in automation, data analytics, and regulatory complexity, the immunoprotein diagnostic testing market presents both significant opportunities and operational risks. Informed strategies will optimize innovation trajectories and deliver measurable value as healthcare needs evolve globally.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunoprotein Diagnostic Testing Market, by Assay Type
8.1. Introduction
8.2. Antibody Test
8.2.1. Iga
8.2.2. Ige
8.2.3. Igg
8.2.4. Igm
8.2.5. Total Antibody
8.3. Antigen Test
8.4. Autoantibody Test
9. Immunoprotein Diagnostic Testing Market, by Technology
9.1. Introduction
9.2. Clia
9.3. Elisa
9.4. Fluorescence Polarization Immunoassay
9.5. Lateral Flow Immunoassay
9.6. Western Blot
10. Immunoprotein Diagnostic Testing Market, by End User
10.1. Introduction
10.2. Clinic
10.3. Diagnostic Laboratory
10.4. Hospital
10.5. Research Institute
11. Immunoprotein Diagnostic Testing Market, by Application
11.1. Introduction
11.2. Autoimmune Disorders
11.2.1. Multiple Sclerosis
11.2.2. Rheumatoid Arthritis
11.2.3. Sjogren Syndrome
11.2.4. Type 1 Diabetes
11.3. Cardiovascular Diseases
11.4. Infectious Diseases
11.4.1. COVID-19
11.4.2. Hepatitis
11.4.3. Hiv
11.4.4. Influenza
11.5. Oncology
12. Immunoprotein Diagnostic Testing Market, by Sample Type
12.1. Introduction
12.2. Plasma
12.3. Serum
12.4. Urine
12.5. Whole Blood
13. Americas Immunoprotein Diagnostic Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Immunoprotein Diagnostic Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Immunoprotein Diagnostic Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Thermo Fisher Scientific Inc
16.3.5. Danaher Corporation
16.3.6. Ortho-Clinical Diagnostics, Inc.
16.3.7. bioMérieux SA
16.3.8. DiaSorin S.p.A
16.3.9. Bio-Rad Laboratories, Inc.
16.3.10. Fujirebio Inc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET MULTI-CURRENCY
FIGURE 2. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOANTIBODY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY FLUORESCENCE POLARIZATION IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SJOGREN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COVID-19, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 67. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 71. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 72. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 75. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 80. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 115. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 116. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 121. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 124. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 129. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 139. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 140. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 144. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 145. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 146. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 147. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 148. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 152. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 153. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 178. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 180. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 184. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 185. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 194. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 195. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 196. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 200. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 201. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 202. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 203. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 204. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 209. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 224. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 225. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 227. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 228. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 232. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 233. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 234. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 235. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 236. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 240. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 241. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 250. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 251. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 252. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 256. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 257. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 258. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 259. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 260. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 264. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 265. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 273. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 283. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 284. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 285. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 289. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 290. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 291. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 292. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 293. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2030 (USD MILLION)
TABLE 297. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 298. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 299. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 300. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 301. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Immunoprotein Diagnostic Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • Danaher Corporation
  • Ortho-Clinical Diagnostics, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A
  • Bio-Rad Laboratories, Inc.
  • Fujirebio Inc

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.08 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Immunoprotein Diagnostic Testing - Global Strategic Business Report - Product Image

Immunoprotein Diagnostic Testing - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
Immunoprotein Market by Product, Application, End User, Technology, Distribution Channel - Global Forecast to 2030 - Product Image

Immunoprotein Market by Product, Application, End User, Technology, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
2025 Global Immunoprotein Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 13 Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers - Product Image

2025 Global Immunoprotein Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 13 Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers

  • Report
  • 297 Pages
  • Global
From

About the Immunoprotein Testing Market

Immunoprotein testing is a type of diagnostic test used to detect the presence of specific proteins in the body. These proteins are produced by the immune system in response to a variety of conditions, including infections, autoimmune diseases, and cancer. Immunoprotein tests are used to diagnose and monitor a wide range of diseases, including HIV, hepatitis, and tuberculosis. They can also be used to detect the presence of antibodies, which can indicate a previous exposure to a particular virus or bacteria. Immunoprotein tests are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA). These tests are often used in combination with other diagnostic tests, such as blood tests, to provide a more comprehensive picture of a patient's health. The immunoprotein testing market is a rapidly growing segment of the diagnostics industry. It is driven by the increasing prevalence of infectious diseases, the growing demand for personalized medicine, and the development of new technologies. Some of the major players in the immunoprotein testing market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.